CL2A

Molecular Formula: C50H79N9O16
Molecular Weight: 1062.20
CAS Number: 2616704-22-2
Note: Prices are for comparison only. Contact Sales for current pricing.
Packing size: 5 mg  
Packing size: 10 mg  
Packing size: 50 mg  
Packing size: 100 mg  



Safety Information


Hazard Statements

H302
H315
H319
H335

Precautionary Statements

P280
P301 + P312
P305 + P351 + P338
P261
P302 + P352

Pictograms

 Product Description

The CL2A is a high-quality component designed for use in various applications. It stands out due to its durability and reliability, making it a preferred choice among professionals. This item is known for its ability to withstand harsh conditions, ensuring consistent performance over time. Its design incorporates advanced technology, allowing for efficient operation and minimal maintenance requirements. Whether used in industrial settings or everyday environments, the CL2A delivers exceptional value and longevity.

 

Application

The CL2A finds its utility in a wide range of applications, from manufacturing processes to general maintenance tasks. Its versatility makes it suitable for both heavy-duty and light-duty operations. Users appreciate its ease of use and the peace of mind it offers knowing they have a reliable tool at their disposal.

 

 

Articles:

- Humanized Anti-Trop-2 IgG-SN-38 Conjugate for Effective Treatment of Diverse Epithelial Cancers: Preclinical Studies in Human Cancer Xenograft Models and Monkeys

Publication Date: MAY 15 2011

Thomas M. Cardillo; Serengulam V. Govindan; Robert M. Sharkey; Preeti Trisal; David M. Goldenberg

https://doi.org/10.1158/1078-0432.CCR-10-2939

 

- Antibody-drug conjugates targeting TROP-2 and incorporating SN-38: A case study of anti-TROP-2 sacituzumab govitecan

Publication Date: 18 Jul 2019

David M. Goldenberg & Robert M. Sharkey

https://doi.org/10.1080/19420862.2019.1632115

 

- A narrow quantitative trait locus in C. elegans coordinately affects longevity, thermotolerance, and resistance to paraquat

Publication Date: 27 September 2011

Anthony Vertino, Srinivas Ayyadevara, John J. Thaden, Robert J. Shmookler Reis

https://doi.org/10.3389/fgene.2011.00063